Description
PharmaQo Turinabol 10 delivers 10 mg Chlorodehydromethyltestosterone (Turinabol) per oral tablet, supplied in 100-tablet packs for research use. Turinabol is under investigation for its anabolic effects, nitrogen retention, lean tissue preservation, and potential applications in metabolic and recovery studies.
With a low androgenic profile and no aromatization, it is frequently used in investigational settings focusing on anabolic activity without estrogenic side effects.
Product Details:
Active Ingredient:
-
Chlorodehydromethyltestosterone (Turinabol)
Concentration: 10 mg per tablet
Form: Oral tablets
Packaging: 100 tablets per pack
Pharmacokinetics:
Turinabol has an oral half-life of ~16 hours, supporting once-daily dosing in research protocols.
Usage Recommendations:
-
Indications (Research Context): Investigational use in anabolic and nitrogen retention models, lean mass studies (not approved for human use)
-
Typical Dosage (Research Use): 20–50 mg per day, depending on study design
-
Monitoring: Liver enzymes, lipid profile, cardiovascular status, androgenic markers
-
Cycle/Duration: 6–8 weeks under research protocols
Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical risks. Always adhere to local research laws and ethical guidelines.